These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17130808)

  • 1. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.
    Renard E; Costalat G; Chevassus H; Bringer J
    Diabetes Metab; 2006 Dec; 32(5 Pt 2):497-502. PubMed ID: 17130808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with an implanted closed-loop insulin delivery system.
    Renard E
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):349-54. PubMed ID: 18438546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances toward the implantable artificial pancreas for treatment of diabetes.
    Jaremko J; Rorstad O
    Diabetes Care; 1998 Mar; 21(3):444-50. PubMed ID: 9540030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.
    Jacobs PG; El Youssef J; Castle JR; Engle JM; Branigan DL; Johnson P; Massoud R; Kamath A; Ward WK
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():397-400. PubMed ID: 22254332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable continuous glucose sensors.
    Renard E
    Curr Diabetes Rev; 2008 Aug; 4(3):169-74. PubMed ID: 18690897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled drug delivery in the treatment of diabetes mellitus.
    Irsigler K; Kritz H; Lovett RG
    Crit Rev Ther Drug Carrier Syst; 1985; 1(3):189-280. PubMed ID: 3912064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an artificial pancreas at home.
    Renard E; Farret A; Place J; Wojtusciszyn A; Bringer J
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S94-8. PubMed ID: 22208718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus).
    Taylor MJ; Gregory R; Tomlins P; Jacob D; Hubble J; Sahota TS
    Int J Pharm; 2016 Mar; 500(1-2):371-8. PubMed ID: 26691655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of artificial endocrine pancreas. From bedside-, wearable-type to implantable one.
    Shichiri M; Kawamori R; Yamasaki Y
    Med Prog Technol; 1987; 12(1-2):39-50. PubMed ID: 3627019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop.
    Dassau E; Palerm CC; Zisser H; Buckingham BA; Jovanovic L; Doyle FJ
    Diabetes Technol Ther; 2009 Mar; 11(3):187-94. PubMed ID: 19191486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed-loop insulin delivery-the path to physiological glucose control.
    Steil GM; Panteleon AE; Rebrin K
    Adv Drug Deliv Rev; 2004 Feb; 56(2):125-44. PubMed ID: 14741112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring considerations for the development of a closed-loop artificial pancreas system.
    Keenan DB; Grosman B; Clark HW; Roy A; Weinzimer SA; Shah RV; Mastrototaro JJ
    J Diabetes Sci Technol; 2011 Nov; 5(6):1327-36. PubMed ID: 22226249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.